"On January 7, 2010, FDA approved an updated Atripla label including new efficacy, safety and resistance data in treatment experienced patients from a trial (Study 073: A Phase IV, Open-Label, Randomized, Multicenter Study Evaluating Efficacy "...
Important: Ask your doctor or pharmacist about medicines that should not be taken with SUSTIVA. For more information, see the section “What should I tell my doctor before taking SUSTIVA?”
Read this Patient Information before you start taking SUSTIVA and each time you get a refill. There may be new information. This information does not take the place of talking with your doctor about your medical condition or treatment.
What is SUSTIVA?
SUSTIVA is a prescription HIV-1 (Human Immunodeficiency Virus type 1) medicine used with other antiretroviral medicines to treat HIV-1 infection in adults and in children who are at least 3 months old and who weigh at least 7 pounds 12 ounces (3.5 kg). HIV is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).
It is not known if SUSTIVA is safe and effective in children younger than 3 months of age or who weigh less than 7 pounds 12 ounces (3.5 kg).
When used with other antiretroviral medicines to treat HIV-1 infection, SUSTIVA may help:
- reduce the amount of HIV-1 in your blood. This is called viral load.
- increase the number of CD4+ (T) cells in your blood that help fight off other infections
Reducing the amount of HIV-1 and increasing the CD4+ (T) cells in your blood may help improve your immune system. This may reduce your risk of death or getting infections that can happen when your immune system is weak (opportunistic infections).
SUSTIVA does not cure HIV-1 infection or AIDS. You must keep taking HIV-1 medicines to control HIV-1 infection and decrease HIV-related illnesses.
Avoid doing things that can spread HIV-1 infection to others:
- Do not share or reuse needles or other injection equipment.
- Do not share personal items that can have blood or body fluids on them, like toothbrushes and razor blades.
- Do not have any kind of sex without protection. Always practice safer sex by using a latex or polyurethane condom to lower the chance of sexual contact with any body fluids such as semen, vaginal secretions, or blood.
Ask your doctor if you have any questions about how to prevent passing HIV to other people.
Who should not take SUSTIVA?
Do not take SUSTIVA if you are allergic to efavirenz or any of the ingredients in SUSTIVA. See the end of this leaflet for a complete list of ingredients in SUSTIVA.
What should I tell my doctor before taking SUSTIVA?
Before taking SUSTIVA, tell your doctor if you have any medical conditions and in particular, if you:
- have ever had a mental health problem
- have ever used street drugs or large amounts of alcohol
- have liver problems, including hepatitis B or C virus infection
- have a history of seizures
- are pregnant or plan to become pregnant. SUSTIVA may harm your unborn baby. You should not become pregnant while taking SUSTIVA and for 12 weeks after stopping treatment with SUSTIVA.
Females who are able to become pregnant must use 2 effective forms of birth control during treatment and for 12 weeks after stopping treatment with SUSTIVA. A barrier form of birth control must be used along with another type of birth control.
- Barrier forms of birth control may include latex or polyurethane condom, contraceptive sponge, diaphragm with spermicide, and cervical cap.
- Hormonal forms of birth control, such as birth control pills, injections, vaginal rings, or implants may not work during treatment with SUSTIVA.
- Talk to your doctor about forms of birth control that may
be used during treatment with SUSTIVA.
Pregnancy Registry. There is a pregnancy registry for women who take antiretroviral medicines during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your doctor about how you can take part in this registry.
- are breastfeeding or plan to breastfeed. You should not breastfeed if you have HIV because of the risk of passing HIV to your baby. Do not breastfeed if you take SUSTIVA. SUSTIVA can pass into your breast milk. It is not known if this could harm your baby. Talk with your doctor about the best way to feed your baby.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
SUSTIVA may affect the way other medicines work, and other medicines may affect how SUSTIVA works, and may cause serious side effects. If you take certain medicines with SUSTIVA, the amount of SUSTIVA in your body may be too low and it may not work to help control your HIV infection. The HIV virus in your body may become resistant to SUSTIVA or other HIV medicines that are like it.
You should not take SUSTIVA if you take ATRIPLA (efavirenz, emtricitabine, tenofovir disoproxil fumarate) unless your doctor tells you to.
Especially tell your doctor if you take any of the medicines below:
The following medicines may need to be replaced with another medicine during your treatment with SUSTIVA:
- boceprevir (Victrelis)
- carbamazepine (Carbatrol, Tegretol, Tegretol-XR, Equetro, Teril, Epitol)
- clarithromycin (Biaxin, Biaxin XL)
- itraconazole (Sporanox, Onmel)
- posaconazole (Noxafil)
- saquinavir mesylate (Invirase)
- atazanavir sulfate (REYATAZ)
If you take any of the following medicines during treatment with SUSTIVA, your doctor may need to change the dose of the medicine or change the dose of SUSTIVA, or your doctor may need to monitor you more closely:
- calcium channel blockers such as diltiazem (Cardizem, Cardizem CD, Cardizem LA, Tiazac, Cartia XT, Dilacor XR, Dilt-CD, Diltzac, Taztia XT), verapamil (Covera-HS, Calan, Calan SR, Verelan, Verelan PM) felodipine (Plendil), nicardipine (Cardene, Cardene SR), or nifedipine (Adalat CC, afeditab CR, Procardia, Procardia XL)
- the cholesterol-lowering medicines atorvastatin (Lipitor), pravastatin sodium (PRAVACHOL), or simvastatin (Zocor)
- immunosuppressant medicines such as cyclosporine (Gengraf, Neoral, Sandimmune), tacrolimus (Prograf, Astagraf XL), or sirolimus (Rapamune)
- artemether/lumefantrine (Coartem)
- atazanavir sulfate (REYATAZ)
- bupropion (Wellbutrin, Wellbutrin SR, Wellbutrin XL, Forfivo XL, Zyban)
- indinavir (Crixivan)
- lopinavir/ritonavir (Kaletra)
- ritonavir (Norvir)
- maraviroc (Selzentry)
- methadone (Dolophine, Methadose)
- rifabutin (Mycobutin)
- rifampin (Rifadin, Rimactane, Rifamate, Rifater)
- sertraline (Zoloft)
- voriconazole (Vfend). Your doses of both Vfend and SUSTIVA may need to be changed.
- raltegravir (Isentress)
- telaprevir (Incivek)
- warfarin (Coumadin, Jantoven)
- phenytoin (Dilantin)
- ketoconazole (Nizoral)
Ask your doctor or pharmacist if you are not sure if your medicine is one that is listed above.
Know the medicines you take. Keep a list of your medicines and show it to your doctor and pharmacist when you get a new medicine.
Your doctor and your pharmacist can tell you if you can take these medicines with SUSTIVA. Do not start any new medicines while you are taking SUSTIVA without first talking with your doctor or pharmacist. You can ask your doctor or pharmacist for a list of medicines that can interact with SUSTIVA.
How should I take SUSTIVA?
- Take SUSTIVA exactly as your doctor tells you to.
- Do not change your dose or stop taking SUSTIVA unless your doctor tells you to.
- Stay under the care of your doctor during treatment with SUSTIVA.
- SUSTIVA must be used with other antiretroviral medicines.
- Take SUSTIVA 1 time each day.
- SUSTIVA comes as tablets or capsules.
- SUSTIVA tablets should not be broken.
- Swallow SUSTIVA tablets or capsules whole with liquid.
How and when to take SUSTIVA
- You should take SUSTIVA on an empty stomach at bedtime. Taking SUSTIVA with food increases the amount of medicine in your body. Some side effects may bother you less if you take SUSTIVA on an empty stomach and at bedtime.
- Your child's doctor will prescribe the right dose of SUSTIVA based on your child's weight.
- If you have difficulty swallowing tablets or capsules, tell your doctor. Your doctor may recommend opening the SUSTIVA capsule and mixing the contents with food or infant formula. See the detailed “Instructions for Use” at the end of this Patient Information to learn the right way to take SUSTIVA using the capsule sprinkle method.
- Adults and children who take SUSTIVA using the capsule sprinkle method should not eat for 2 hours after taking a dose of SUSTIVA.
- Babies should not be given infant formula for 2 hours after taking a dose of SUSTIVA using the capsule sprinkle method.
- Do not miss a dose of SUSTIVA. If you forget to take SUSTIVA, take the missed dose right away, unless it is almost time for your next dose. Do not take 2 doses at one time. Just take your next dose at your regularly scheduled time. If you need help in planning the best times to take your medicine, ask your doctor or pharmacist.
- If you take too much SUSTIVA, call your doctor or go to the nearest hospital emergency room right away.
- When your SUSTIVA supply starts to run low, get more from your doctor or pharmacy. It is important not to run out of SUSTIVA. The amount of HIV in your blood may increase if the medicine is stopped for even a short time. The virus may become resistant to SUSTIVA and harder to treat.
What are the possible side effects of SUSTIVA?
SUSTIVA may cause serious side effects, including:
- Serious mental health problems can happen in
people who take SUSTIVA. Tell your doctor right away if you have any of the
- feel sad or hopeless
- feel anxious or restless
- have thoughts of hurting yourself (suicide) or have tried to hurt yourself or others
- are not able to tell the difference between what is true or real and what is false or unreal
- do not trust other people
- hear or see things that are not real
- Nervous system symptoms are common in people who
take SUSTIVA and can be severe. These symptoms usually begin during the first
or second day of treatment with SUSTIVA and usually go away after 2 to 4 weeks
of treatment. These symptoms may become worse if you drink alcohol, take a
medicine for mental health problems, or use certain street drugs during treatment
with SUSTIVA. Symptoms may include:
- trouble sleeping
- unusual dreams
- trouble concentrating
If you have dizziness, trouble concentrating or drowsiness, do not drive a car, use machinery, or do anything that needs you to be alert.
- Skin rash is common with SUSTIVA but can sometimes
be severe. Skin rash usually goes away without any change in treatment. If you
develop a rash with any of the following symptoms, tell your doctor right away:
- skin rash, with or without itching
- swelling of your face
- blisters or skin lesions
- peeling skin
- mouth sores
- red or inflamed eyes, like “pink eye” (conjunctivitis)
- Liver problems, including liver failure and death. If you have liver problems, including hepatitis B or C infection or take
another medicine that can cause liver problems, your doctor may do blood tests
to check your liver before you start SUSTIVA and during treatment. Liver
problems can also happen in people without a history of liver problems. Tell
your doctor right away if you get any of the following symptoms:
- your skin or the white part of your eyes turns yellow (jaundice)
- your urine turns dark
- your bowel movements (stools) turn light in color
- you don't feel like eating food for several days or longer
- you feel sick to your stomach (nausea)
- you have lower stomach area (abdominal) pain
- Seizures can happen in people who take SUSTIVA. Seizures are more likely to happen if you have had seizures in the past. Tell your doctor if you have had a seizure or if you take a medicine to help prevent seizures.
- Changes in your immune system (Immune Reconstitution Syndrome) can happen when you start taking HIV-1 medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. Tell your doctor if you start having new symptoms after starting your HIV-1medicine.
- Changes in body fat can happen in people who take HIV-1 medicine. These changes may include increased amount of fat in the upper back and neck (“buffalo hump”), breast, and around the main part of your body (trunk). Loss of fat from the legs, arms, and face may also happen. The cause and long-term health effects of these conditions are not known.
The most common side effects of SUSTIVA include:
- abnormal dreams
- trouble sleeping
- difficulty concentrating
Some patients taking SUSTIVA have experienced increased levels of lipids (cholesterol and triglycerides) in the blood. Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of SUSTIVA. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store SUSTIVA?
- Store SUSTIVA capsules and tablets at room temperature between 68°F to 77°F (20°C to 25°C).
Keep SUSTIVA and all medicines out of the reach of children.
General information about SUSTIVA
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use SUSTIVA for a condition for which it was not prescribed. Do not give SUSTIVA to other people, even if they have the same symptoms that you have. It may harm them.
If you would like more information, talk with your doctor. You can ask your pharmacist or doctor for information about SUSTIVA that is written for health professionals. For more information, go to www.sustiva.com or call 1-800-321-1335.
What are the ingredients in SUSTIVA?
Active ingredient: efavirenz
SUSTIVA capsules: lactose monohydrate, magnesium stearate, sodium lauryl sulfate, and sodium starch glycolate. The capsule shell contains gelatin, sodium lauryl sulfate, titanium dioxide, and/or yellow iron oxide. The capsule shell may also contain silicon dioxide. The capsules are printed with ink containing carmine 40 blue, FD&C Blue No. 2, and titanium dioxide.
SUSTIVA tablets: croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and sodium lauryl sulfate. The tablet film coating contains Opadry Yellow and Opadry Clear. The tablets are polished with carnauba wax and printed with purple ink, Opacode WB.
This Patient Information has been approved by the U.S. Food and Drug Administration.
Distributed by: Bristol-Myers Squibb Company Princeton, NJ 08543 USA SUSTIVA® (efavirenz) capsules made in India. © Bristol-Myers Squibb Company 201X. Revised: May 2014
Instructions for Use
(sus-TEE-vah) efavirenz capsules
Preparing a dose of SUSTIVA using the capsule sprinkle method
Read this Instructions for Use before you prepare your first dose of SUSTIVA mixed with food or infant formula using the capsule sprinkle method, each time you get a refill, and as needed. There may be new information. This information does not take the place of talking to your doctor about your medical condition or treatment. Ask your doctor or pharmacist if you have any questions about how to mix or give a dose of SUSTIVA using the capsule sprinkle method.
- For more information about SUSTIVA capsules, see the Patient Information leaflet.
- The capsule sprinkle method for mixing the contents of SUSTIVA capsules with soft food or infant formula may be used for adults or children who cannot swallow capsules or tablets.
- You should take SUSTIVA on an empty stomach at bedtime.
- You should not eat for 2 hours after taking SUSTIVA mixed with food.
- Babies who are old enough to swallow food should be given SUSTIVA using the capsule sprinkle method mixed with food instead of with infant formula.
- Talk with your doctor to help decide the best schedule for giving your baby SUSTIVA mixed with infant formula using the capsule sprinkle method.
Preparing a dose of SUSTIVA mixed with food using the capsule sprinkle method.
Before you prepare a dose of SUSTIVA mixed with food using the capsule sprinkle method, gather the following supplies:
- paper towels
- small spoon
- small clean container (such as a small cup or bowl)
- soft food such as applesauce, grape jelly, or yogurt
Step 1. Choose a clean, flat work surface. Place a clean paper towel on the work surface. Then place the other supplies on the paper towel.
Step 2. Wash and dry your hands well.
Step 3. Place 1 to 2 teaspoons of soft food such as applesauce, grape jelly, or yogurt in the small container (see Figure A). The color and thickness of the food may change when mixed with the medicine.
Step 4. There are 2 parts of the SUSTIVA capsule. Look at the SUSTIVA capsule to see which part of the capsule overlaps the other part (see Figure B).
Step 5. Turn the SUSTIVA capsule so that you are holding it in a sideways (horizontal) position directly over the container of food. Hold each end of the SUSTIVA capsule between your thumbs and index (pointer) fingers (see Figure C).
Step 6. Use your thumb and index finger to pinch near the end of the overlapping part of the SUSTIVA capsule (see Figure D).
Then, carefully twist both ends of the SUSTIVA capsule in opposite directions to open it (see Figure E). Be careful not to spill the capsule contents or spread it in the air.
Step 7. Sprinkle the contents of the SUSTIVA capsule onto the food (see Figure F). Throw away the empty capsule shells.
If the total prescribed dose is more than 1 capsule, follow Steps 4 through 7 for each capsule. Do not add more food.
Steps 8 through 11 must be completed within 30 minutes of mixing the medicine.
Step 8. Use a spoon to gently mix the capsule contents and food together (see Figure G).
Step 9. Use the spoon to take the food and capsule contents mixture or feed it to your child. Swallow all of the mixture. If you are giving the mixture to your child, look in your child's mouth to make sure that all of the mixture is swallowed.
Step 10. Add about 2 teaspoons more of the food to the empty container and gently stir to mix with any capsule contents that may still be in the container.
Step 11. Use the spoon to take the mixture or feed it to your child. Swallow all of the mixture. If you are giving the mixture to your child, look in your child's mouth to make sure that all of the mixture is swallowed.
Step 12. Wash the container and spoon. Throw away the paper towel and clean the work surface.
Step 13. Wash your hands.
Preparing a dose of SUSTIVA mixed with infant formula using the capsule sprinkle method
Before you prepare a dose of SUSTIVA mixed with infant formula using the capsule sprinkle method, gather the following supplies:
- paper towels
- small spoon
- 30 milliliter (mL) medicine cup (ask your pharmacist for this). See Figure H.
- 10 mL oral dosing syringe (ask your pharmacist for this). See Figure H.
- infant formula at room temperature. If you are using powdered formula, you should prepare the formula according to the formula directions before mixing with SUSTIVA capsule contents.
Step 1. Choose a clean, flat work surface. Place a clean paper towel on the work surface. Place the supplies you will need on the paper towel.
Step 2. Wash and dry your hands well.
Step 3. Pour 10 mL of room temperature infant formula into the 30 mL medicine cup (see Figure I).
Step 4. There are 2 parts of the SUSTIVA capsule. Look at the SUSTIVA capsule to see which part of the capsule overlaps the other part (see Figure J).
Step 5. Turn the SUSTIVA capsule so that you are holding it in a sideways (horizontal) position directly over the medicine cup that contains the infant formula. Hold each end of the SUSTIVA capsule between your thumbs and index (pointer) fingers (see Figure K).
Step 6. Use your thumb and index finger to pinch near the end of the overlapping part of the SUSTIVA capsule (see Figure L).
Then, carefully twist both ends of the SUSTIVA capsule in opposite directions to open it (see Figure M). Be careful not to spill the capsule contents or spread it in the air.
Step 7. Sprinkle the contents of the SUSTIVA capsule onto the infant formula (see Figure N). Throw away the empty capsule shells.
If the total prescribed dose is more than 1 capsule, follow Steps 4 through 7 for each capsule. Do not add more infant formula.
Steps 8 through 11 must be completed within 30 minutes of mixing the medicine.
Step 8. Hold the medicine cup with one hand. With your other hand, use the small spoon to gently mix the capsule contents and the infant formula (see Figure O).
Step 9. Draw up the capsule contents and infant formula mixture into the 10 mL oral dosing syringe as follows:
- Check that the plunger is completely pushed into barrel of the syringe (see Figure P).
- Place the tip of the syringe into the capsule contents and infant formula mixture in the medicine cup (see Figure Q).
- Slowly pull back on the plunger and draw up all of the mixture (see Figure R).
Step 10. Place the tip of the oral dosing syringe in your baby's mouth along the inner cheek on either the right or left side (see Figure S). Slowly push on the plunger to give your baby all of the SUSTIVA capsule contents and infant formula mixture.
To make sure that your baby gets all of the medicine, do not give SUSTIVA capsule contents to your baby in a bottle.
Step 11. To make sure there is no capsule contents and formula mixture left in the medicine cup or syringe:
- Repeat Step 3 above to add 10 mL more infant formula into the medicine cup.
- Stir with a small spoon.
- Then, repeat Steps 9 and 10 above.
Step 12. Remove the plunger from the oral dosing syringe. Wash the medicine cup, spoon, and oral dosing syringe. Allow the medicine cup, spoon, and oral dosing syringe to dry. Throw away the paper towel and clean the work surface.
Step 13. Wash your hands.
How should I store SUSTIVA capsules?
- Store SUSTIVA capsules at room temperature between 68°F to 77°F (20°C to 25°C).
Keep SUSTIVA capsules and all medicines out of the reach of children.
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Last reviewed on RxList: 6/5/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Sustiva Information
Sustiva - User Reviews
Sustiva User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.